Related Experiment Video
Updated: Jan 31, 2026

Automated Microbial Cultivation and Adaptive Evolution using Microbial Microdroplet Culture System MMC
Published on: February 18, 2022
From birth to beyond: predicting incidence and timing of CSF diversion in postnatal MMC closure
Katherine Daniels1, Kelsi M Chesney2, Brannan E O'Neill3
1Princeton University, Princeton, NJ, USA.
Insights
Myelomeningocele (MMC) patients often develop hydrocephalus requiring shunts. Elevated frontal-occipital horn ratio (FOHR) and hydrocephalus (HCP) at birth predict shunt need and timing in MMC patients.
Area of Science:
- Pediatric Neurosurgery
- Spina Bifida Research
- Hydrocephalus Management
Background:
- Myelomeningocele (MMC) is associated with a high incidence of shunt-dependent hydrocephalus.
- Ventriculoperitoneal shunts (VPS) are frequently required but increase lifetime morbidity for individuals with MMC.
Purpose of the Study:
- To identify risk factors for VPS placement in MMC patients.
- To determine the incidence and timing of VPS insertion.
- To improve outcomes and inform family counseling regarding hydrocephalus in MMC.
Main Methods:
- Retrospective review of 125 patients undergoing postnatal MMC closure (1998-2022).
- Analysis of VPS placement, age at insertion, and comparison between shunted and shunt-free cohorts.
- Utilized Mann-Whitney U, Welch's t-test, Fisher's exact test, and Youden's index to identify predictive factors and optimal thresholds for hydrocephalus (HCP) and frontal-occipital horn ratio (FOHR).
Main Results:
- 69% of MMC patients required VPS, with 94% placed within 2 months of birth.
- Higher FOHR and HCP at birth predicted VPS placement.
- FOHR was a significant predictor of earlier VPS insertion (optimal threshold >0.48).
Conclusions:
- Elevated FOHR and HCP at birth are predictive of shunt-dependent hydrocephalus in MMC patients.
- Specific thresholds (FOHR >0.48, HCP >50%) can aid in early identification and management.
- These findings support improved family counseling and timely intervention for hydrocephalus in MMC.
Purpose:
Up to 87% of individuals with myelomeningocele (MMC) develop shunt-dependent hydrocephalus, and ventriculoperitoneal shunts (VPS) significantly increase lifetime morbidity. This study aimed to identify risk factors, incidence, and timing of VPS placement to improve outcomes and guide family counseling.
Methods:
A retrospective review of 125 patients who underwent postnatal MMC closure at Children's National Hospital between 1998 and 2022 was conducted. Primary outcomes were VPS placement and age at insertion. VPS and shunt-free cohorts were compared using Mann-Whitney U, Welch's t-test, and Fisher's exact test (α = 0.05). Subanalysis examined patients shunted within 2 weeks versus 2 weeks-2 months. Youden's index determined optimal cutoffs for hydrocephalus (HCP) and frontal-occipital horn ratio (FOHR).
Results:
Sixty-nine percent of MMC patients received VPS. Among shunted patients, 16% received VPS at closure, 61% within 2 weeks, and 94% within 2 months; no shunts were placed after 1 year. Mean follow-up was 10.7 years. Higher FOHR (p < 0.0001) and HCP (p = 0.01) at birth predicted VPS placement, though only FOHR predicted earlier insertion (0.55 vs 0.48; p = 0.0003). Optimal predictive thresholds were FOHR > 0.48 and HCP > 50%.
Conclusion:
In this cohort, 69% of MMC patients developed shunt-dependent hydrocephalus. Elevated FOHR at birth predicted earlier VPS placement, and FOHR > 0.48 and HCP > 50% were predictive of VPS need. These measures may aid in family counseling and early identification of patients requiring shunting.
More Related Videos
Related Concept Videos
Birth Control Methods
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Predicting Molecular Geometry
Diversity of Archaea I
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Cell Diversity
Multicellular...

